On a recent episode of GEN Live, the editors of GEN spoke with Oppenheimer analyst Leland Gershell, MD, PhD, who shared some fascinating insights regarding current trends facing the biopharma industry. Leland discusses how the markets are weathering the challenges posed by COVID-19, the reasons behind the recent M&A and IPO activity, and what's to come in the future of biopharma . . .

Get GEN Edge Today!